Mechanisms of Immune Evasion by Tumors
- 1 January 2006
- book chapter
- review article
- Published by Elsevier BV in Advances in Immunology
- Vol. 90, 51-81
- https://doi.org/10.1016/s0065-2776(06)90002-9
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunityNature Reviews Immunology, 2004
- BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Nature Immunology, 2003
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisOncogene, 2002
- Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34+ progenitor cellsHuman Immunology, 2001
- Clonal deletion of thymocytes as a tumor escape mechanismInternational Journal of Cancer, 1998
- High frequency of altered HLA class I phenotypes in invasive breast carcinomasHuman Immunology, 1996
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- Phenotypic expression of histocompatibility antigens in human primary tumours and metastasesClinical & Experimental Metastasis, 1989
- Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breastThe Journal of Pathology, 1987